B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• B-cell malignancies like chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are incurable.
• Multiple myeloma is particularly prone to relapse.
• The role of RANK signaling in B-cell transformation and tumor microenvironment is not fully understood.

Purpose of the Study:

• To develop a novel mouse model for B-cell malignancies with active RANK signaling and the TCL1 oncogene.
• To investigate the differential impacts of RANK activation in B1- and B2-cells.
• To explore the role of RANK signaling in shaping a tumor-supportive microenvironment.

Main Methods:

• Development of a novel mouse model with active RANK signaling and TCL1 oncogene.
• Analysis of CLL and MM phenotypes in the mouse model.
• Xenotransplantation model using human MM cells to test RANK inhibition.

Main Results:

• The novel mouse model exhibits both CLL and MM phenotypes.
• RANK activation in B1-cells promotes CLL-like B-lymphocytes, while in B2-cells it drives MM.
• The induced MM in mice mimics human disease features and promotes a tumor-supportive microenvironment.
• Inhibition of RANK signaling reduces MM progression in a xenotransplantation model.

Conclusions:

• RANK signaling plays a differential role in B1- and B2-cell transformation, influencing CLL and MM development.
• Targeting RANK signaling may represent a therapeutic strategy for multiple myeloma.
• This study provides a foundation for further research into RANK's role in B-cell malignancies and tumor microenvironment modulation.